Prediction of recurrence with the Oncotype DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial.

被引：4

作者：

Penault-Llorca, Frederique Madeleine

Filleron, Thomas

Asselain, Bernard

Baehner, Frederick L.

Fumoleau, Pierre

Lacroix-Triki, Magali

Butler, Steven M.

Jamshidian, Farid

Cherbavaz, Diana B.

Shak, Steven

Roca, Lise

Sagan, Christine

Lemonnier, J.

Martin, Anne-Laure

Roche, Henri Hubert

机构：

[1] Ctr Jean Perrin, Clermont Ferrand, France

[2] Inst Claudius Regaud, Toulouse, France

[3] Curie Site Paris, Paris, France

[4] Genom Hlth Inc, Redwood City, CA USA

[5] Ctr Georges Francois Leclerc, Dijon, France

[6] Inst Reg Canc Montpellier Val dAurelle, Montpellier, France

[7] Inst Cancerol Ouest Site Rene Gauducheau, St Herblain, France

[8] R&D UNICANC, Paris, France

来源：

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.11052

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

11052

引用

页数：1